During the past decade, Institute for Advanced Medical Research conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 30 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 18 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Advanced Medical Research" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 6 trials sponsored, "Pfizer" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Sunovion" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Advanced Medical Research" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Forest Laboratories" with 1 trials as a collaborator, "Institute for Advanced Medical Research, Alpharetta, GA" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Advanced Medical Research" are "Atopic Dermatitis" (9 trials), "Depressive Disorder, Major" (8 trials), "Major Depressive Disorder" (6 trials), "Plaque Psoriasis" (5 trials) and "Psoriasis" (5 trials). Many other conditions were trialed in "Institute for Advanced Medical Research" in a lesser frequency.

Most popular intervention types in "Institute for Advanced Medical Research" are "Drug" (44 trials), "Other" (6 trials), "Biological" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Lebrikizumab" (6 trials), "Rapastinel" (6 trials), "Dasotraline" (3 trials) and "Ixekizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Advanced Medical Research" are 48 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute for Advanced Medical Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Institute for Advanced Medical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Advanced Medical Research, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".